title: Polymyositis associated with infliximab treatment for rheumatoid arthritis.
authors.forename: Yukitomo
authors.initials: Y
authors.lastname: Urata
authors.forename: Yuji
authors.initials: Y
authors.lastname: Wakai
authors.forename: Kenji
authors.initials: K
authors.lastname: Kowatari
authors.forename: Taisuke
authors.initials: T
authors.lastname: Nitobe
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Mizushima
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D017285:Polymyositis / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D011239:Prednisolone / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D011239:Prednisolone; D000069285:Infliximab; D008727:Methotrexate